1 October we become SureStone CapitalSame team, same ABN. Our website and email addresses move to surestone.com.au.
Learn more

Health Care ASX Announcements

Plain-English summaries of selected price-sensitive ASX announcements in the Health Care sector. Every summary is drawn only from the company's official release.

Wednesday, 12 August 2026

1 announcement

Pro Medicus Limited (ASX:PME)
OperationsPrice Sensitive

Pro Medicus Signs A$23m 7-Year St. Luke's Contract

Pro Medicus subsidiary Visage Imaging has signed a 7-year, A$23M contract with St. Luke's Health System in Idaho, with go-live targeted for Q1 of calendar 2027.

Pro Medicus Limited (ASX:PME)

9:13 am

12 Aug 2026

Friday, 7 August 2026

1 announcement

Resmed Inc. (ASX:RMD)
QuarterlyPrice Sensitive

Resmed Q4 FY26 Revenue Up 9% to Record $1.46 Billion

Resmed reported Q4 FY26 revenue of $1,464m, up 9%, with non-GAAP diluted EPS up 16% to $2.95. The board declared a quarterly dividend of $0.66, up 10%.

Resmed Inc. (ASX:RMD)

8:26 am

7 Aug 2026

Wednesday, 5 August 2026

1 announcement

Neuren Pharmaceuticals Limited (ASX:NEU)
QuarterlyPrice Sensitive

Acadia Q2 DAYBUE Sales US$125m Lift Neuren Royalties

Neuren reported partner Acadia's Q2 2026 DAYBUE net sales of US$125m, up 30%, and said its own full-year 2026 royalty income is now expected at US$53-56m.

Neuren Pharmaceuticals Limited (ASX:NEU)

9:52 am

5 Aug 2026

Tuesday, 4 August 2026

1 announcement

Amplia Therapeutics Limited (ASX:ATX)
ClinicalPrice Sensitive

Amplia Signs Lilly Trial Collaboration in Lung Cancer

Amplia signed a clinical trial collaboration with Eli Lilly to evaluate narmafotinib with olomorasib in non-small cell lung cancer, planned to begin late 2026.

Amplia Therapeutics Limited (ASX:ATX)

8:22 am

4 Aug 2026

Monday, 3 August 2026

1 announcement

Regis Healthcare Limited (ASX:REG)
OperationsPrice Sensitive

Regis to Buy Royal Freemasons Victorian Home Care Unit

Regis Healthcare has agreed to buy Royal Freemasons' Victorian home care business and its 480 clients, expected to lift annualised home care revenue to $50m.

Regis Healthcare Limited (ASX:REG)

8:37 am

3 Aug 2026

Friday, 31 July 2026

1 announcement

Mayne Pharma Group Limited (ASX:MYX)
ResultsPrice Sensitive

Mayne Pharma FY26 Revenue $383.7m, EBITDA Down 33%

Mayne Pharma posted unaudited FY26 revenue of $383.7 million, down 6%, with underlying EBITDA of $31.7 million, down 33%, and a 65% FY26 gross margin.

Mayne Pharma Group Limited (ASX:MYX)

9:29 am

31 Jul 2026

Thursday, 30 July 2026

1 announcement

Clinuvel Pharmaceuticals Limited (ASX:CUV)
ClinicalPrice Sensitive

Clinuvel Sets Vitiligo Benchmarks Before CUV105 Data

Clinuvel published peer reviewed vitiligo benchmarks for narrowband UVB and JAK inhibitors ahead of topline CUV105 results for SCENESSE due in December 2026.

Clinuvel Pharmaceuticals Limited (ASX:CUV)

8:57 am

30 Jul 2026

Wednesday, 29 July 2026

1 announcement

CSL Limited (ASX:CSL)
ClinicalPrice Sensitive

CSL to Trial Enhanced Horizon 2 Plasma Manufacturing

CSL will trial immunoglobulin made with its yield-enhancing Horizon 2 process, with clinical activities to begin in mid-2027 after FDA and EMA engagement.

CSL Limited (ASX:CSL)

9:21 am

29 Jul 2026

Other sectors

EnergyMaterialsFinancialsIndustrialsInformation TechnologyConsumer DiscretionaryReal Estate

← Back to Daily ASX Announcement Summaries

Copyright © 2026 Ausbiz Capital